AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+38.55%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$2.94B
AUM Growth
+$2.94B
(+40%)
Cap. Flow
-$16M
Cap. Flow
% of AUM
-0.55%
Top 10 Holdings %
Top 10 Hldgs %
47.94%
Holding
134
New
28
Increased
21
Reduced
57
Closed
5
Top Buys
| 1 |
GDS Holdings
GDS
|
$87.6M |
| 2 |
Generation Bio
GBIO
|
$59.1M |
| 3 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$37.7M |
| 4 |
Royalty Pharma
RPRX
|
$36.4M |
| 5 |
NovaGold Resources
NG
|
$23.9M |
Top Sells
| 1 |
Moderna
MRNA
|
$161M |
| 2 |
Avantor
AVTR
|
$42.5M |
| 3 |
PayPal
PYPL
|
$41.8M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$29.6M |
| 5 |
Zillow
Z
|
$24M |
Sector Composition
| 1 | Healthcare | 75.63% |
| 2 | Consumer Discretionary | 16.28% |
| 3 | Technology | 3.84% |
| 4 | Financials | 1.19% |
| 5 | Communication Services | 0.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRNB
51
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $12M | 0.33% | 200,000 -50,000 | -20% | -$2.99M |
|
52
StoneCo
STNE
$4.41B
| $11.2M | 0.31% | 290,000 -110,000 | -28% | -$4.26M |
|
|
AGEN
53
Agenus
AGEN
$133M
| $11.2M | 0.31% | 2,850,000 +350,000 | +14% | +$1.38M |
|
54
Cyclerion Therapeutics
CYCN
$7.91M
| $10.9M | 0.3% | 1,841,584 -20,000 | -1% | -$118K |
|
55
Denali Therapeutics
DNLI
$2.23B
| $10.9M | 0.3% | 450,000 -50,000 | -10% | -$1.21M |
|
56
Spyre Therapeutics
SYRE
$996M
| $10.2M | 0.28% | 1,100,000 +700,000 | +175% | +$6.48M |
|
|
SAGE
57
DELISTED
Sage Therapeutics
SAGE
| $9.73M | 0.27% | 234,000 -116,000 | -33% | -$4.82M |
|
|
IMAB
58
I-MAB
IMAB
$340M
| $9.7M | 0.27% | 324,000 -26,000 | -7% | -$778K |
|
59
Ascendis Pharma
ASND
$11.8B
| $9.61M | 0.27% | 65,000 -35,000 | -35% | -$5.18M |
|
60
Kura Oncology
KURA
$686M
| $9.42M | 0.26% | 578,000 +178,000 | +45% | +$2.9M |
|
61
Adaptive Biotechnologies
ADPT
$2.01B
| $9.1M | 0.25% | 188,000 -12,000 | -6% | -$581K |
|
|
AXDX
62
DELISTED
Accelerate Diagnostics
AXDX
| $8.89M | 0.25% | 586,500 -13,500 | -2% | -$205K |
|
63
Regenxbio
RGNX
$451M
| $8.62M | 0.24% | 234,000 -16,000 | -6% | -$589K |
|
64
Krystal Biotech
KRYS
$4.27B
| $8.28M | 0.23% | 200,000 +100,000 | +100% | +$4.14M |
|
65
Cartesian Therapeutics
RNAC
$261M
| $8.24M | 0.23% | 2,900,000 -513,629 | -15% | -$1.46M |
|
|
IMMU
66
DELISTED
Immunomedics Inc
IMMU
| $8.18M | 0.23% | +230,838 | New | +$8.18M |
|
|
TCDA
67
DELISTED
Tricida, Inc. Common Stock
TCDA
| $7.83M | 0.22% | 285,000 -75,000 | -21% | -$2.06M |
|
68
Akebia Therapeutics
AKBA
$833M
| $7.8M | 0.22% | 574,000 +149,000 | +35% | +$2.02M |
|
|
TRIL
69
DELISTED
Trillium Therapeutics Inc.
TRIL
| $7.71M | 0.22% | 953,000 -47,000 | -5% | -$380K |
|
70
ProQR Therapeutics
PRQR
$237M
| $7.66M | 0.21% | 1,259,177 -40,823 | -3% | -$248K |
|
71
Bruker
BRKR
$5.16B
| $7.51M | 0.21% | +184,500 | New | +$7.51M |
|
72
Spero Therapeutics
SPRO
$116M
| $7.37M | 0.21% | 545,040 -30,960 | -5% | -$419K |
|
73
Immunic
IMUX
$80.9M
| $7.27M | 0.2% | 600,000 -30,019 | -5% | -$364K |
|
|
HOOK
74
DELISTED
HOOKIPA Pharma
HOOK
| $6.97M | 0.2% | 599,616 -196,643 | -25% | -$2.29M |
|
75
Stoke Therapeutics
STOK
$1.08B
| $6.79M | 0.19% | 285,000 +35,000 | +14% | +$834K |
|